We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

78 hedge funds and large institutions have $74.4M invested in abrdn Life Sciences Investors in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

4% more capital invested

Capital invested by funds: $71.9M → $74.4M (+$2.54M)

0.21% more ownership

Funds ownership: 20.76% → 20.97% (+0.21%)

0% more funds holding

Funds holding: 78 → 78 (0)

Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RL
RPO LLC
Connecticut
+$2.57M
2
SCM
Saba Capital Management
New York
+$1.89M
3
TJHA
Thomas J. Herzfeld Advisors
Florida
+$1.43M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$1.26M
5
AA
AQR Arbitrage
Connecticut
+$688K

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$2.01M
2
FHA
Flagship Harbor Advisors
Massachusetts
-$1.87M
3
LSC
Logan Stone Capital
Illinois
-$1.01M
4
WAM
Wolverine Asset Management
Illinois
-$978K
5
Wells Fargo
Wells Fargo
California
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$835K -$68.3K -4,954 -7%
QC
27
Quantedge Capital
Singapore
$795K +$458K +33,200 +130%
Stifel Financial
28
Stifel Financial
Missouri
$730K -$62.1K -4,500 -8%
Walleye Capital
29
Walleye Capital
New York
$721K -$42.7K -3,097 -5%
WP
30
Woodline Partners
California
$716K – – –
UBS Group
31
UBS Group
Switzerland
$652K +$29.2K +2,117 +5%
BFM
32
Boothbay Fund Management
New York
$622K +$634K +45,969 New
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$612K -$202K -14,651 -24%
AUB
34
Atlantic Union Bankshares
Virginia
$535K -$135K -9,774 -20%
Qube Research & Technologies (QRT)
35
Qube Research & Technologies (QRT)
United Kingdom
$507K – – –
KWM
36
Kingsview Wealth Management
Oregon
$497K -$6.5K -471 -1%
AWS
37
Atria Wealth Solutions
New York
$447K -$75.9K -5,501 -14%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$446K +$17.7K +1,284 +4%
NA
39
NewEdge Advisors
Louisiana
$418K +$25.1K +1,817 +6%
GC
40
Guggenheim Capital
Illinois
$379K +$41.7K +3,021 +12%
LCM
41
Landscape Capital Management
New Jersey
$368K -$93.8K -6,802 -20%
JP Morgan Chase
42
JP Morgan Chase
New York
$280K +$286K +20,709 +1,035,450%
WS
43
Wedbush Securities
California
$267K +$23.8K +1,724 +10%
PAG
44
Private Advisor Group
New Jersey
$265K – – –
Cerity Partners
45
Cerity Partners
New York
$249K +$254K +18,408 New
OC
46
Oppenheimer & Co
New York
$233K +$5.33K +386 +2%
LOPW
47
Live Oak Private Wealth
North Carolina
$194K +$331 +24 +0.2%
Invesco
48
Invesco
Georgia
$193K -$566 -41 -0.3%
NFG
49
Nations Financial Group
Iowa
$188K – – –
AW
50
Atlas Wealth
Ohio
$177K +$181K +13,090 New
1
2
3 4

HQL Hedge Fund Activity: Q2 2023 in Review

78 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2023, worth a combined $74.4M — up 3.5% from $71.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HQL positions and 7 closed out — a net gain of 1 holder — while 34 added to existing stakes and 19 trimmed.

The largest buyer was RPO LLC, opening a new position worth an estimated $2.57M. The largest seller was Raymond James & Associates, cutting an estimated $2.01M.

  • 78 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $74.4M of abrdn Life Sciences Investors stock for Q2 2023, up 3.5% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q2 2023 and 7 closed out, a net change of +1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q2 2023 was RPO LLC, an estimated $2.57M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2023 was Raymond James & Associates, an estimated $2.01M sold.

Based on aggregated 13F filings for Q2 2023.